Member Info for Rudey

There will be lots of interested parties, Bronx.

The company are getting cash up front with new contracts and must be awash with the horrible stuff. lol

insert vox markets.co.uk

You could try these relax360.

https://soundcloud.com/doc-h-4/6-5-20-interview-cathal-friel

****************************/articles/open-orphan-salt-lake-potash-cadence-minerals-paul-hill-0dc7654

https://www.brrmedia.co.uk/broadcasts-embed/5eafeec931da814c9fc6d56a/event/?previewEventId=5eafeec931da814c9fc6d56a&popup=true

https://www.proactiveinvestors.co.uk/companies/news/918729/open-orphan-s-cathal-friel-details-new-35mln-rsv-study-agreement-918729.html

Go away Fairview, and do some research.

Things are going to move so fast in so many unexpected ways, in my opinion it's too risky to sell hoping to buy back cheaper.
New contracts for human challenge studies for vaccines to be announced.
New contracts for antivirals to be tested.
Remote challenge study operations.
Imutex vending into another company and progress.
Ultimate sale of Open Orphan as a lucrative going concern.

All within around 6 months. Too risky to trade.

I think he was referring to swinger, Bazzaman.

'The plan would be to sell later this year for a reasonable sum of money'

I believe it's leased Shareseeker10.

A couple of mentions for hVIVO there Bill. Thanks.

Momentum is building for a Human Challenge Study. Maybe the only hold up now is an antiviral.

'The value of the Imutex asset at the moment is hard to say, however when we come to sell the company the likely buyer will be another CRO and they won’t want the product business so vending it in to another company will have two benefits: 1) it will make the sale of Open Orphan more interesting and desirable to a CRO company and 2) the other value is that shareholders now will have a direct stake in a second plc. As such at this point in time we can’t put a value on Imutex but we do think it would be very considerable should we find the right public vehicle to vend into and should it prove successful going forward.'

https://academic.oup.com/view-large/figure/201727780/jiaa152f0001.jpg

The process to vaccine licensure through a controlled human challenge trial and large study to assess short-term safety (black) compared to the conventional phase 3 trial route to licensure (grey). Submission for licensure could occur substantially earlier with a controlled human challenge trial.

https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa152/5814216?searchresult=1

Capital gains is 10%, and the limit before paying is about 11k (unless things have changed in the last couple of years), so I won't begrudge paying the tax on my ENORMOUS profits from my Imutex shares. Very happy with his plans.

If my understanding is correct, oilbagger, finding a safe replacement for use in a challenge study may delay the process of finding a suitable vaccine, so it may be best to give volunteers the genuine article in the safest and most closely monitored environment possible to speed things up.

Thanks Dynam1cs.

These bulletin boards are programmed to remove certain websites, so it's best to put the link you are referring to with an additional '.' at some point, and say which '.' needs to be removed. I hope that helps. Thanks for the posts.

I've checked on all of the alternative company's share prices that I had recently considered investing my savings in, and I'm sure by choosing ORPH I've made the right decision. Thanks Cathal.

Good weekend all.

Indeed. I just got a very interesting email too. He clearly wants to make rapid progress.

10.4p to buy.

Looks like you shook things up today Swaplebar.